abstract |
The present invention relates to nucleolipid-based compounds for use in regenerative medicine. More specifically, the invention relates to the use of to nucleolipid-based compounds in bioink gel formulations and a bioprinting method comprising the use of a bioink formulation comprising said nucleolipid-based compounds. The invention further relates to a bioprinted construct comprising nucleolipid-based compound(s) and bioink gel formulations. |